HCG18 and hepatocellular carcinoma: To determine the clinical value of the ceRNAs network in HCC, survival analysis was conducted, revealing that HCC patients with high expression of HCG18, SNHG16 or RRM2 had poor prognosis, whereas those with high expression of miR-30a-5p demonstrated a longer survival period (Fig. 1g).